Iopamidol

Overview

Iopamidol is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200932).

API suppliers (7)

Suppliers of Iopamidol evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• Zhejiang Starry Pharmaceutical Co., LtdChina2 active DMF
• Divis LaboratoriesIndia1 active DMF GMP on record
• SUZHOU RYWAY BIOTECH CO LTD1 active DMF
• BRACCO IMAGING SPA1 active DMF GMP on record
• RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPAItaly GMP on record
• HOVIONE SOCIEDADE QUIMICA SA
• ZAMBON GROUP SPA

EU CEP holders (5)

Companies holding a valid EU Certificate of Suitability (CEP) for Iopamidol, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Patent & exclusivity (US)

Per the FDA Orange Book (14 approved US products), the latest listed US patent on Iopamidol expires — and exclusivity 10 Oct 2028. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

1-N,3-N-bis(1,3-dihydroxypropan-2-yl)-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodobenzene-1,3-dicarboxamide

Canonical SMILES

C[C@@H](C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O

InChIKey

XQZXYNRDCRIARQ-LURJTMIESA-N